Labshake search
Citations for R&D Systems :
151 - 200 of 3652 citations for 6 Amino 4 hydroxy 3 7 sulfo 4 4 sulfophenyl azo 1 naphthyl azo naphthalene 2 7 disulfonic acid sodium salt since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Cell Biology 2021Quote: ... 30 ng/ml Bone morphogenic protein-4 (BMP4) (R&D systems), 1.5 μM CHIR99021 (Stemgent) ...
-
bioRxiv - Microbiology 2020Quote: ... and 4,000 U/ml of rh IL-4 (R&D Systems) and cultured for 5 days ...
-
bioRxiv - Neuroscience 2022Quote: ... or IL-4 (20 ng/mL, 24 h, R&D Systems). Following stimulation ...
-
bioRxiv - Developmental Biology 2022Quote: ... BMP-4 (40 ng/ml, R&D Systems #5020-BP-010) or CHIR99021 (3 μM ...
-
bioRxiv - Cancer Biology 2022Quote: ... The caspase 4 inhibitor (Z-YVAD-FMK, FMK005, R&D systems) was used in further experiments at the dose of 50 µM ...
-
bioRxiv - Neuroscience 2023Quote: ... 4 µl of anti-V5-AF647 antibody (R&D Systems, FAB8926R) was used for staining cells for 20 minutes on a shaker at 500 rpm (Thermo Microplate Shaker) ...
-
bioRxiv - Molecular Biology 2023Quote: ... and growth factors: 5 ng/ml BMP-4 (R&D Systems), 9 ng/ml Activin A (R&D Systems) ...
-
bioRxiv - Bioengineering 2023Quote: ... and 20 ng/mL human recombinant FGF-4 (R&D Systems). After 9 to 13 days ...
-
bioRxiv - Microbiology 2024Quote: ... and IL-4 (R&D Systems, Cat# 6507-IL-025/CF) in complete RPMI ...
-
bioRxiv - Immunology 2024Quote: ... TNFα and IL-4 using ELISA kits from R&D Systems in accordance with the manufacturer’s instructions ...
-
bioRxiv - Immunology 2023Quote: ... were diluted to 4 µg/ml in PBS along with 1 µg/ml VCAM-1-Fc (R&D Systems). To coat ...
-
bioRxiv - Immunology 2020Quote: ... grids were incubated with sheep anti-STING antibody at 1:7 dilution (AF6516, R&D Systems), rinsed in PBS ...
-
bioRxiv - Molecular Biology 2024Quote: ... Resting or ADP (10 μM)-stimulated platelets (4 × 103/μL) were pretreated with the inhibitor hDcR3 (10 μg/mL, recombinant human decoy receptor 3 protein, R&D Systems) for 10 min and then allowed to adhere to the coated coverslips for 60 min at RT under normoxic or hypoxic conditions ...
-
bioRxiv - Neuroscience 2024Quote: ... Cells were passaged by dissociation in 0.5 mM EDTA every 3-4 days and resuspended in Essential 8 Medium supplemented with Y-27632 dihydrochloride (10 μM; Cat.#1254; R&D Systems). For CRISPR-Cas9 editing ...
-
bioRxiv - Bioengineering 2024Quote: ... Hydrogels (n=3) were incubated for 4 hours in a solution of FBS-free DMEM supplemented with 10% Resazurin dye (AR002, R&D Systems) at 37°C ...
-
bioRxiv - Cancer Biology 2022Quote: ... incubated overnight at 4°C in the following primary antibodies: T-LCK (1:1000 R&D Systems), T-LCK (1:1000 Proteintech) ...
-
bioRxiv - Neuroscience 2021Quote: ... incubated for 5 days at 4°C with Car4 primary antibody (1:500, RRID:AB_10013483; R&D Systems), rinsed ...
-
bioRxiv - Neuroscience 2023Quote: ... The cells were labeled with anti-human SSEA-4 APC-conjugated antibody (1:100, R&D Systems) at 37°C for 30 minutes ...
-
bioRxiv - Neuroscience 2023Quote: ... Tissues were stained overnight at 4°C with mouse CD45 antibody (1:200; Af114, R&D Systems). The next day ...
-
bioRxiv - Immunology 2022Quote: ... cells were washed at day 7 and cultured at 0.5.106 cells/ml with 50 U/ml IL-2 (R&D Systems), 250 U/ml IFN-α (R&D Systems) ...
-
bioRxiv - Immunology 2020Quote: ... IL-7 and stem cell factor (all from R&D systems) in α-MEM (Gibco ...
-
bioRxiv - Immunology 2022Quote: ... and IL-7 (50 ng/ml, R&D systems, #407-ML). After 2 to 4 weeks ...
-
bioRxiv - Biochemistry 2023Quote: ... His10-FLAG-BRD4 (0.2 μL, 7 μM, R&D Systems, SP600100), ubiquitin (10 μL ...
-
bioRxiv - Cancer Biology 2024Quote: ... and recombinant human IL-7 (5 ng/mL) (R&D Systems).
-
bioRxiv - Synthetic Biology 2021Quote: ... in a 1:1 ratio with 100 U mL-1 of IL-7 and 10U mL-1 IL-15 (R&D Systems) in tissue culture flasks ...
-
bioRxiv - Neuroscience 2021Quote: 10 ng/mL BMP-4 (R&D Systems cat. no. 314-BP)
-
bioRxiv - Immunology 2020Quote: ... and IL-4 (R&D Systems cat. 404-ML, 10 ng/ml) in RPMI 1640 medium (Gibco cat ...
-
bioRxiv - Immunology 2020Quote: ... 25ng/ml IL-4 (404-ML-025, R&D Systems, Minneapolis MN) and 25ng/ml IL-21(210-21 ...
-
bioRxiv - Immunology 2019Quote: ... and 5 ng/ml IL-4 (R&D Systems, #404-ML-010). After 24-72 hr the cells were resuspended by pipetting ...
-
bioRxiv - Immunology 2019Quote: ... and 10 μg/ml of anti–IL-4 antibody (R&D Systems) were added at D0 ...
-
bioRxiv - Immunology 2019Quote: ... and 10 μg/ml of anti–IL-4 antibody (R&D Systems) were added to RP10 media at day 0 ...
-
bioRxiv - Biochemistry 2021Quote: Four 4× stock solutions were prepared containing (i) Ube1 (R&D Systems) + UbcH5c/UBE2D3 (R&D Systems ...
-
bioRxiv - Immunology 2020Quote: ... and IL-4 (R&D Systems cat. 204-IL, 35 ng/ml) in RPMI 1640 medium supplemented with 10% FBS and 2-Mercaptoethanol ...
-
bioRxiv - Cell Biology 2022Quote: ... and Laminin (R&D Systems #3446-005-01, 4-8 µg/cm2) coated glass-bottom Petri dishes (Greiner Bio-One #627975 ...
-
bioRxiv - Cancer Biology 2023Quote: ... Th2 condition: Recombinant human IL-4 (10 ng/ml, R&D Systems), IL-5 (10 ng/ml ...
-
bioRxiv - Neuroscience 2023Quote: ... and stage-specific embryonic antigen-4 (SSEA4, R&D Systems, Minneapolis, USA) using immunocytochemistry (ICC) ...
-
bioRxiv - Immunology 2023Quote: ... Concentration of sCTLA-4 was estimated by ELISA (R&D Systems, DY476) or SDS-PAGE/CBB staining with bovine serum albumin (BSA ...
-
bioRxiv - Genomics 2023Quote: ... followed by recombinant human BMP-4 (5 ng/mL; R&D Systems) and CHIR 99021 (1 nM ...
-
CRISPR-Cas9 Engineered Extracellular Vesicles for the Treatment of Dominant Progressive Hearing LossbioRxiv - Bioengineering 2023Quote: ... specimens were stained with anti-4 hydroxynonenal (R&D Systems MSB 3249) or anti 3-nitrotyrosine ...
-
bioRxiv - Neuroscience 2023Quote: ... or anti-toll-like receptor 4 (TLR4; clone #610029, R&D Systems). All antibodies were titrated using negative control cells that don’t or poorly express the target protein ...
-
bioRxiv - Cell Biology 2024Quote: ... and 0.25 ng/mL recombinant human BMP-4 Protein (R&D Systems).Cells were cultured for 28 hours ...
-
Low-dose cytokine immunotherapy of solid cancers enabled by phagocytic-competent protein co-crystalsbioRxiv - Cancer Biology 2023Quote: ... 3 and 6 days and subsequently tested by IL-2 ELISA (R&D Systems) according to the manufacturer’s protocol.
-
bioRxiv - Immunology 2023Quote: ... the pellets obtained after centrifugation of the BAL fluid were pooled and stained for 30 min at 4°C with unconjugated polyclonal goat anti-mouse Ym1/2 (AF2446, R&D Systems; 1:100 diluted in PBS). After washing ...
-
bioRxiv - Neuroscience 2021Quote: ... offspring at postnatal day 3 to 6 received 7 intraperitoneal injections with either PBS (controls) or 75 ng of carrier free recombinant mouse interleukin-6 (rmIL6, R&D Systems, Minneapolis MN).
-
bioRxiv - Developmental Biology 2020Quote: ... the membranes were incubated overnight at 4°C with anti-Gremlin1 antibody (R&D systems, AF956, 1:1000) or anti-βActin (Santa Cruz ...
-
bioRxiv - Neuroscience 2020Quote: ... The blots were incubated overnight at 4 °C with goat anti Dscam (AF3666, 1:500, R&D systems) and mouse anti-tubulin (12G10 ...
-
bioRxiv - Cancer Biology 2020Quote: ... Membranes were incubated overnight at 4°C with primary antibodies against pLCK (Y394) (1:1000) (R&D Systems), GAPDH (1:1000 ...
-
bioRxiv - Cell Biology 2022Quote: ... and incubated overnight at 4°C with antibodies against ACE2 (1:400; R&D systems, Minneapolis, MN, USA), TMPRSS2 (1:1000 ...
-
bioRxiv - Molecular Biology 2023Quote: ... The cell pellet was stained for 1 hour at 4°C with primary ACE2 antibody (R&D systems #AF933 ...
-
bioRxiv - Bioengineering 2022Quote: Transduced/Transfected and sorted hGICs harbouring either Lentivirus-MGT#1 or PiggyBac-MGT#1/4 were seeded as single cells into 6-well plates in RHB-A medium supplemented with 10ng/ml TNFa (R&D Systems, 210-TA-020) or without TNFa as control ...